BRICKELL BIOTECH, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementBrickell Biotech, Inc. • April 14th, 2020 • Biological products, (no disgnostic substances) • New York
Company FiledApril 14th, 2020 Industry JurisdictionBrickell Biotech, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc. (the “Agent”) as follows: